Trends & Forecasts

Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

AI is set to be a key disruptor in the pharma industry. Here are two perspectives on how it could change drug development.

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Why mRNA will be a key disrupter in the coming years; experts from CureVac and Omega Therapeutics give their views.

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

What lies ahead for the future of pharma? Dennis van Rooji gives his view.

Accelerating the progress of cell and gene therapies with decentralized trials and other innovative approaches.

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.